A Study of Tetanus Antibody of Healthy Adults
NCT07724379 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2009
Last updated 2026-07-24
Summary
The goal of this observational study is to learn about antibody level of tetanus of adults in high-income city of china. The main question it aims to answer is:
1. Analysis of tetanus antibody distribution across different age groups
2. Evaluation of the TQS method for determining antibody status
3. Correlation between primary vaccination history and tetanus antibody concentrations Blood samples were voluntarily provided by adult healthy participants for tetanus antibody analysis over a continuous collection period of more than one year.
Conditions
- Tetanus
Sponsors & Collaborators
-
Peking University First Hospital
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2025-05-04
- Primary Completion
- 2026-03-03
- Completion
- 2026-05-15
Countries
- China
Study Locations
More Related Trials
-
Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Recombinant Human Anti-Tetanus Toxin Monoclonal Antibody Injection
NCT07149454 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE1
-
Phase I/II Clinical Trial of Diphtheria-Tetanus-Pertussis (Reduced Dose) Vaccine
NCT07418372 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
Tetanus Immunization in Subjects With No Immunization History or With Tetanus Antibody Levels Below Protective Levels
NCT00437671 ·Status: TERMINATED ·Phase: PHASE4
-
A Phase 3 Study of BIBP Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed
NCT05091619 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Antibody Persistence to REVAXIS or DT Polio and Immune Response to TETRAVAC-ACELLULAIRE
NCT01546909 ·Status: COMPLETED ·Phase: PHASE4
-
A Phase I Clinical Trial of Absorbed Acellular Pertussis (Two-Component) Diphtheria-Tetanus Combined Vaccine (For Adults and Adolescents)
NCT07492303 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
Antitetanus Vaccination for People Older Than 65 Years.
NCT03266211 ·Status: COMPLETED
-
Adsorption of Cell-free Diphtheria and Tetanus (Three-component) Combined With Vaccine Phase III Clinical Trial
NCT07112144 ·Status: RECRUITING ·Phase: PHASE3
-
Clinical Study on the Combined Administration of 15-Valent Pneumococcal Conjugate Vaccine and Diphtheria, Tetanus, Pertussis Vaccine
NCT06817187 ·Status: COMPLETED ·Phase: PHASE3
-
A Clinical Trial of Adsorbed Cell-free DPT Vaccine (5-component) (for People Aged 6 Years and Above)
NCT06056050 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed in Healthy Subjects
NCT02587520 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Persistency Study After Hib-CRM (Cross-Reacting Material)197 or Hib-TT (Tetanus Toxoid) Vaccines in Chinese Children
NCT02139228 ·Status: COMPLETED ·Phase: PHASE3
-
Phase I Clinical Trial of Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed .
NCT04099303 ·Status: COMPLETED ·Phase: PHASE1
-
Sanofi Pasteur's Tdap Combined Vaccine as a Booster Versus Local DT Vaccine in Children or Versus Local Td Vaccine in Adolescents and Adults in China.
NCT01993173 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Immunogenicity Study of a Diphtheria, Tetanus, Acellular Pertussis and Poliomyelitis Vaccine (REPEVAX) Followed by 2 Doses of a Diphtheria, Tetanus and Poliomyelitis Vaccine (REVAXIS) in Subjects of 40 Years of Age or Older
NCT01287949 ·Status: COMPLETED ·Phase: PHASE3
-
A Clinical Trial of Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed(DTcP)
NCT05951725 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
A Study on the Immune Response and Safety of a Combined Vaccine Against Diphtheria, Tetanus and Acellular Pertussis (dTpa) in Japanese Healthy Pregnant Women
NCT07596199 ·Status: RECRUITING ·Phase: PHASE3
-
Intrathecal Tetanus Immunoglobulin to Treat Tetanus
NCT02999815 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study to Assess the Safety & Reactogenicity of GSK Biologicals' DTPa/Hib Vaccine When Given at 3, 4 and 5 Months of Age
NCT00379977 ·Status: COMPLETED ·Phase: PHASE3
-
Immunogenicity and Safety of DTaP or DT Vaccine in 6 Year Old Children ( DTaP/DT )
NCT05870631 ·Status: UNKNOWN ·Phase: PHASE4
-
10-year Follow-up After a Single Dose Acellular Pertussis Vaccination
NCT06803524 ·Status: RECRUITING ·Phase: PHASE4
-
Phase I Clinical Trial of Diphtheria-Tetanus-acellular Pertussis Component Combined Vaccine
NCT06184542 ·Status: RECRUITING ·Phase: PHASE1
-
Study of Reduced-antigen-content Acellular Pertussis Vaccine and Diphtheria-Tetanus-Acellular Pertussis Vaccine
NCT01262924 ·Status: COMPLETED ·Phase: PHASE3
-
Studies of In Vitro B Lymphocyte Responses in Subjects Receiving Tetanus Toxoid Booster Immunization
NCT00001173 ·Status: COMPLETED
-
Immunogenicity and Safety of DTaP or DT Vaccine in 6 Year Old Children
NCT05870618 ·Status: UNKNOWN ·Phase: PHASE4